Heron Therapeutics Inc (NASDAQ:HRTX)

Data as of Jan 30
 -0.46 / -5.50%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-7.3M-11.8M-23.3M-55.3M
Total Other Cash Flow1.9M2.4M5.0M11.4M
Funds From Operations-5.2M-9.3M-18.1M-43.5M
Funds From/For Other Operating Expenses267.0K-1.5M-1.1M-2.8M
Net Cash Flow - Operating Activities-5.5M-7.7M-17.0M-40.8M
InvestingCapital Expenditures-78.0K-513.0K-972.0K-1.7M
Net Cash Flow Investing-78.0K-513.0K-972.0K-1.7M
FinancingShort Term Borrowings0.000.003.0M0.00
Long Term Borrowings0.001.3M0.000.00
Long Term Debt Reduction0.
Net Proceeds Stock Sale77.0K22.8M50.5M61.2M
Common Preferred Redeemed0.
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.
Net Cash Flow - Financing77.0K24.1M53.5M61.2M
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
Net Change In Cash-5.5M15.9M35.5M18.8M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.